Quantbot Technologies LP Lowers Stock Position in American Healthcare REIT, Inc. (NYSE:AHR)

Quantbot Technologies LP decreased its position in American Healthcare REIT, Inc. (NYSE:AHR) by 57.9% in the fourth quarter, Holdings Channel reports. The institutional investor owned 124,839 shares of the company’s stock after selling 171,978 shares during the period. Quantbot Technologies LP’s holdings in American Healthcare REIT were worth $3,548,000 as of its most recent filing with the SEC.

Other hedge funds have also modified their holdings of the company. Principal Financial Group Inc. boosted its position in American Healthcare REIT by 54.1% during the third quarter. Principal Financial Group Inc. now owns 9,488,750 shares of the company’s stock worth $247,654,000 after purchasing an additional 3,330,714 shares in the last quarter. Wellington Management Group LLP lifted its position in shares of American Healthcare REIT by 25.7% during the 3rd quarter. Wellington Management Group LLP now owns 13,445,752 shares of the company’s stock valued at $350,934,000 after buying an additional 2,747,960 shares in the last quarter. State Street Corp lifted its position in shares of American Healthcare REIT by 221.6% during the 3rd quarter. State Street Corp now owns 3,683,691 shares of the company’s stock valued at $96,473,000 after buying an additional 2,538,177 shares in the last quarter. FMR LLC acquired a new stake in American Healthcare REIT in the 3rd quarter valued at $56,575,000. Finally, Cbre Investment Management Listed Real Assets LLC purchased a new stake in American Healthcare REIT in the 4th quarter worth $33,838,000. 16.68% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

AHR has been the subject of a number of research reports. Morgan Stanley boosted their target price on shares of American Healthcare REIT from $27.00 to $29.00 and gave the stock an “overweight” rating in a research note on Monday, December 30th. JMP Securities set a $35.00 price target on American Healthcare REIT in a research report on Tuesday, March 4th. Citigroup restated an “outperform” rating on shares of American Healthcare REIT in a report on Tuesday, March 4th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $34.00 price objective on shares of American Healthcare REIT in a report on Wednesday. Seven analysts have rated the stock with a buy rating, According to MarketBeat, American Healthcare REIT has a consensus rating of “Buy” and an average price target of $30.83.

American Healthcare REIT Stock Down 0.8 %

NYSE AHR opened at $29.59 on Friday. American Healthcare REIT, Inc. has a 52 week low of $12.81 and a 52 week high of $30.97. The company has a quick ratio of 0.37, a current ratio of 0.37 and a debt-to-equity ratio of 0.59. The business’s fifty day simple moving average is $28.75 and its 200-day simple moving average is $27.26. The firm has a market cap of $4.66 billion and a PE ratio of -61.64.

American Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 17th. Investors of record on Monday, March 31st will be issued a $0.25 dividend. The ex-dividend date of this dividend is Monday, March 31st. This represents a $1.00 annualized dividend and a yield of 3.38%. American Healthcare REIT’s dividend payout ratio (DPR) is currently -370.37%.

American Healthcare REIT Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.